Epigenetic role of nuclear S6K1 in early adipogenesis

被引:4
|
作者
Yi, Sang Ah [1 ]
Han, Jihoon [1 ]
Han, Jeung-Whan [1 ]
机构
[1] Sungkyunkwan Univ, Sch Pharm, Res Ctr Epigenome Regulat, Suwon 16419, South Korea
基金
新加坡国家研究基金会;
关键词
Adipogenesis; Epigenetics; EZH2; Histone modification; S6K1;
D O I
10.5483/BMBRep.2016.49.8.116
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
S6K1 is a key regulator of cell growth, cell size, and metabolism. Although the role of cytosolic S6K1 in cellular processes is well established, the function of S6K1 in the nucleus remains poorly understood. Our recent study has revealed that S6K1 is translocated into the nucleus upon adipogenic stimulus where it directly binds to and phos-phorylates H2B at serine 36. Such phosphorylation promotes EZH2 recruitment and subsequent histone H3K27 trimethylation on the promoter of its target genes including Wnt6, Wnt10a, and Wnt10b, leading to repression of their expression. S6K1-mediated suppression of Wnt genes facilitates adipogenic differentiation through the expression of adipogenic transcription factors PPAR gamma and Cebpa. White adipose tissues from S6K1-deficient mice consistently exhibit marked reduction in H2BS36 phosphorylation (H2BS36p) and H3K27 trimethylation (H3K27me3), leading to enhanced expression of Wnt genes. In addition, expression levels of H2BS36p and H3K27me3 are highly elevated in white adipose tissues from mice fed on high-fat diet or from obese humans. These findings describe a novel role of S6K1 as a transcriptional regulator controlling an epigenetic network initiated by phosphorylation of H2B and trimethylation of H3, thus shutting off Wnt gene expression in early adipogenesis.
引用
收藏
页码:401 / 402
页数:2
相关论文
共 50 条
  • [21] INVESTIGATING THE S6K1 AND S6K2 IN PTEN-DEFICIENT GLIOBLASTOMA
    Sarma, Pranjal
    Ennis, Kelli
    Plas, David R.
    NEURO-ONCOLOGY, 2018, 20 : 45 - 45
  • [22] S6K1 Deficiency Protects Against Apoptosis in Hepatocytes
    Gonzalez-Rodriguez, Agueda
    Alba, Javier
    Zimmerman, Valeri
    Kozma, Sara C.
    Valverde, Angela M.
    HEPATOLOGY, 2009, 50 (01) : 216 - 229
  • [23] SKAR: a novel target of the mTOR/S6K1 pathway
    Juelich, Kristina
    Richardson, Celeste J.
    Ma, Xiaoju Max
    Blenis, John
    EUROPEAN JOURNAL OF PEDIATRICS, 2009, 168 (03) : 383 - 383
  • [24] Regulation of S6K1 by hVps34 is independent of its role in vesicular trafficking
    Flinn, Rory
    Backer, Jonathan
    DIABETES, 2008, 57 : A382 - A382
  • [25] Specific interaction between S6K1 and CoA synthase
    Nemazanyy, I.
    Panasyuk, G.
    Gout, I.
    Filonenko, V.
    EJC SUPPLEMENTS, 2005, 3 (02): : 57 - 58
  • [26] Specific interaction between S6K1 and CoA synthase
    Nemazanyy, I
    Zhyvoloup, A
    Gout, I
    Filonenko, V
    FEBS JOURNAL, 2005, 272 : 311 - 311
  • [27] Immunohistochemical analysis of S6K1 and S6K2 expression in human breast tumors
    Savinska, LO
    Lyzogubov, VV
    Usenko, VS
    Ovcharenko, GV
    Gorbenko, ON
    Rodnin, MV
    Vudmaska, MI
    Pogribniy, PV
    Kyyamova, RG
    Panasyuk, GG
    Nemazanyy, IO
    Malets, MS
    Palchevskyy, SS
    Gout, IT
    Filonenko, VV
    EXPERIMENTAL ONCOLOGY, 2004, 26 (01) : 24 - 30
  • [28] The role of the mTORC1/S6K1 signaling pathway in ER-positive breast cancer
    Holz, M. K.
    Unger, H. A.
    Sedletcaia, A.
    CANCER RESEARCH, 2012, 72
  • [29] Could S6K1 immunopositivity be used to distinguish early and advanced stages of endometrioid endometrial adenocarcinoma?
    Gun, Ismet
    Ozdamar, Ozkan
    Kucukodaci, Zafer
    Muhcu, Murat
    Demirel, Dilaver
    JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2016, 17 (03) : 163 - 167
  • [30] Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
    Perez-Tenorio, Gizeh
    Karlsson, Elin
    Waltersson, Marie Ahnstrom
    Olsson, Birgit
    Holmlund, Birgitta
    Nordenskjold, Bo
    Fornander, Tommy
    Skoog, Lambert
    Stal, Olle
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (03) : 713 - 723